UCSF Study Identifies FTL1 Protein as Key Driver of Brain Aging and Memory Decline in Mice

Scientists at UCSF identify FTL1 as a key driver of memory loss. Lowering this protein in older mice restored neural connections and improved cognitive function.

By: AXL Media

Published: Apr 28, 2026, 8:04 AM EDT

Source: Information for this report was sourced from Nature Aging and University of California, San Francisco.

Discovery of a Molecular Switch for Cognitive Decay

A team of scientists led by Dr. Saul Villeda at the UCSF Bakar Aging Research Institute has uncovered a specific biological mechanism that appears to dictate the pace of brain aging. By analyzing the hippocampus, the primary center for learning and memory, researchers identified that ferritin light chain 1 (FTL1) levels increase significantly as mice grow older. This protein, which is typically involved in cellular iron storage, emerged as the most consistent marker of cognitive decline. The findings suggest that age related memory loss is not merely an inevitable consequence of cellular death but is driven by specific protein imbalances that disrupt the brain’s ability to maintain its internal wiring.

Artificial Aging Induced in Youthful Subjects

To confirm whether FTL1 was a direct cause of cognitive deterioration rather than a secondary symptom, the UCSF team artificially increased the protein's presence in young, healthy mice. The results were immediate and striking, as the younger subjects began to exhibit the hallmarks of geriatric brains. Laboratory observations revealed that neurons flooded with extra FTL1 lost their complex branching structures, resulting in shorter signal sending arms and fewer synaptic connections. These physiological changes translated into poor performance on memory tasks, effectively forcing the young mice to behave with the cognitive limitations of much older animals.

Reversing Impairments Through Protein Suppression

In perhaps the most significant phase of the experiment, researchers attempted to undo the damage by lowering FTL1 levels in 18 month old mice, which is equivalent to late middle age in humans. Upon reducing the protein's presence, the older mice showed a remarkable recovery in hippocampal function. The brain cells began to rebuild lost connections, and the animals' performance on memory tests improved to levels comparable to their younger counterparts. Dr. Villeda noted that the results represent a true reversal of impairments, moving beyond the traditional medical goal of simply delaying or preventing the onset of symptoms.